JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

Rhea-AI Summary

JATT II Acquisition Corp (NASDAQ:JATT) priced a $60,000,000 initial public offering of 6,000,000 ordinary shares at $10.00 per share. Shares are expected to begin trading on April 17, 2026 with the offering expected to close on April 20, 2026.

The company granted underwriters a 45-day option to buy up to 900,000 additional shares to cover over-allotments. A registration statement was declared effective by the SEC on April 16, 2026. Guggenheim Securities is sole book-running manager.

Positive

• Priced a $60,000,000 initial public offering
• Scheduled listing on Nasdaq Global Market under ticker JATT

Negative

• Underwriter option could dilute up to 15% of the IPO shares

News Market Reaction – JATT

+28.68%

+28.68% Session close to close

In the Apr 17 session, JATT gained 28.68%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +28.7% in the session following this news. A strong positive reaction aligns with t...

Analysis

The stock surged +28.7% in the session following this news. A strong positive reaction aligns with the confirmation of IPO pricing at $10.00 per share for 6,000,000 shares, establishing a clear capital base of $60,000,000. Investors often focused on structure and terms may reassess once trading history develops. Over time, factors such as deal quality, redemption levels, and acquisition progress could influence whether initial enthusiasm remained supported.

Key Figures

IPO size: $60,000,000 Shares offered: 6,000,000 ordinary shares IPO price: $10.00 per share +5 more

8 metrics

IPO size $60,000,000 Initial public offering aggregate proceeds

Shares offered 6,000,000 ordinary shares Base IPO share count

IPO price $10.00 per share Initial public offering price

Over-allotment shares 900,000 ordinary shares Additional shares underwriters may purchase

Over-allotment window 45 days Period for underwriters’ option exercise

Trading start date April 17, 2026 Expected NASDAQ trading commencement

IPO closing date April 20, 2026 Expected offering closing date

Effective date April 16, 2026 SEC effectiveness of registration statement

Key Terms

special purpose acquisition company, nasdaq global market, underwriters, registration statement, +2 more

6 terms

special purpose acquisition company financial

"a newly organized special purpose acquisition company formed as a Cayman Islands"

A special purpose acquisition company (SPAC) is a company formed with the sole purpose of raising money through a public offering to buy or merge with an existing private business. It acts like a vehicle that allows private companies to go public more quickly and with less complexity. For investors, it offers an opportunity to invest early in a potential acquisition, though it also carries risks if the intended deal doesn’t materialize.

nasdaq global market financial

"expected to trade on the Nasdaq Global Market (“NASDAQ”) under the ticker symbol"

The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.

underwriters financial

"The Company has granted the underwriters a 45-day option to purchase up to"

Underwriters are financial professionals or institutions that help companies raise money by selling new securities, such as stocks or bonds, to investors. They assess the risk and determine the price at which these securities should be sold, acting like a bridge between the company and the investors. Their role helps ensure that the company raises the needed funds while providing investors with options that reflect the level of risk involved.

registration statement regulatory

"A registration statement relating to the securities sold in the initial public offering"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

securities and exchange commission regulatory

"was declared effective by the U.S. Securities and Exchange Commission (the “SEC”)"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

prospectus regulatory

"The public offering is being made only by means of a prospectus. When available, copies"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share. The ordinary shares are expected to trade on the Nasdaq Global Market (“NASDAQ”) under the ticker symbol “JATT” beginning April 17, 2026. The offering is expected to close on April 20, 2026, subject to customary closing conditions.

Guggenheim Securities, LLC is acting as sole book-running manager. The Company has granted the underwriters a 45-day option to purchase up to 900,000 additional ordinary shares at the initial public offering price to cover over-allotments, if any.

A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on April 16, 2026 (the “Effective Date”). The public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from Guggenheim Securities, LLC, Attn: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery@guggenheimpartners.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About JATT II Acquisition Corp

JATT II Acquisition Corp is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. While the Company may pursue an initial business combination in any business or industry, the Company intends to focus its search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences. In particular, the Company intends to seek businesses that can benefit from the clinical, scientific, operational, strategic and capital markets experience of the management team and board of directors and, in many cases, from access to the public markets as a means of funding continued development, executing strategic transactions and increasing visibility with investors and potential partners. The Company expects to focus particularly, though not exclusively, on businesses applying data-driven approaches, including machine learning, computational biology, structure-based drug design and related technologies, to improve the therapeutic discovery and development process. The Company is sponsored by JATT Ventures II L.P. and is led by Dr. Someit Sidhu, Chief Executive Officer and Chairman of the Board, and Nicholas Fernandez, Chief Financial Officer. The Company’s Board of Directors also includes Verender S. Badial, Arjun Goyal, Jonathon Kluft and Christopher Staral, bringing extensive experience across biotechnology investing, company architecture, and public and private capital markets.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”) including the gross proceeds of the IPO, the anticipated use of the net proceeds from the IPO and the search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or that the net proceeds of the offering will be used as indicated or that the Company will ultimately complete a business combination transaction in the sectors it is targeting or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of JATT II Acquisition Corp, including those set forth in the Risk Factors section of JATT II Acquisition Corp’s registration statement and preliminary prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. JATT II Acquisition Corp undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Nicholas Fernandez
Chief Financial Officer
153 Central Avenue
C/O 56
Westfield, NJ 07091
201-688-0364

FAQ

What did JATT (NASDAQ:JATT) announce about its IPO on April 16, 2026?

JATT priced 6,000,000 ordinary shares at $10.00 per share, totaling $60,000,000 in gross proceeds. According to JATT II Acquisition Corp, the offering is expected to close April 20, 2026, and a 45-day over-allotment option covers up to 900,000 additional shares.

When will JATT ordinary shares begin trading on Nasdaq after the April 16, 2026 IPO filing?

JATT ordinary shares are expected to begin trading on April 17, 2026 on the Nasdaq Global Market. According to JATT II Acquisition Corp, trading starts the day after the SEC declared the registration effective on April 16, 2026.

How large is the underwriters' over-allotment option in the JATT IPO (ticker JATT)?

The underwriters have a 45-day option to buy up to 900,000 additional ordinary shares to cover over-allotments. According to JATT II Acquisition Corp, that represents up to 15% additional shares relative to the base offering.

Who is managing the JATT (NASDAQ:JATT) IPO and how can investors obtain the prospectus?

Guggenheim Securities is the sole book-running manager for the offering. According to JATT II Acquisition Corp, investors can request the prospectus from Guggenheim's Equity Syndicate Department via phone or email listed in the offering notice.

When is the expected closing date for the JATT IPO announced April 16, 2026?

The offering is expected to close on April 20, 2026, subject to customary closing conditions. According to JATT II Acquisition Corp, closing remains contingent on satisfying normal underwriting and regulatory closing requirements.